Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

June 22, 2024
Cutting edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical …
June 22, 2024
This meeting is presented by the Department of Medicine, Division of Oncology at the Washington University School of Medicine in St. Louis. The course will include multiple presentations developed based on new information presented at the ASCO Annual Meeting. These presentations will be placed in the context of updates in treating and diagnosing malignant diseases, with particular highlights in …
June 21, 2024
Evaluating the Evolving Treatment Landscape for mHR+ Breast Cancer-How to Personalize Care and Improve Patient Outcomes This live virtual symposium will bring together a nationally recognized expert in the management of breast cancer and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios. Learn More
June 21, 2024
Evaluating the Evolving Treatment Landscape for mHR+ Breast Cancer-How to Personalize Care and Improve Patient Outcomes This live virtual symposium will bring together a nationally recognized expert in the management of breast cancer and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios. Learn More
ACCCBuzz spotlights RWJBarnabas Health, Rutgers Cancer Institute of New Jersey and Cooperman Barnabas Medical Center, a recipient of the 2024 ACCC Innovator Award.
1 Copyright© 2024 ADVI Health. All Rights Reserved. On May 30, 2024, CMMI released a request for applications (RFA) to solicit applications for a second cohort of participants in the Enhancing Oncology Model (EOM) and to highlight changes to the model. • The RFA is for a second cohort of EOM participants and payers. • The second cohort will begin participation in EOM on July 1, 2025, and end …
June 21, 2024
Overcoming Clinical Challenges and Embracing New Opportunities in the Management of Multiple Myeloma This live, virtual symposium will bring together a nationally recognized expert in the management of multiple myeloma and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios. Learn More
As the first-ever Black female president of the Association of Cancer Care Centers, Nadine J. Barrett, PhD, MA, MPH, understands the impact she will have on the next generation to come. She is a nationally recognized leader in facilitating community/stakeholder and academic partnerships to advance health equity and develop training methods to address implicit bias and structural and systemic racism …
June 20, 2024
Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease This live, virtual symposium will bring together a nationally recognized expert in the management of breast cancer and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios. Learn More
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. SCOS ONCOLOGY DRUG NEWSLETTER J U N E 2 0 2 4 FDA APPROVALS Tisotumab vedotin-tftv (Tivdak) The FDA has granted full approval to tisotumab vedotin-tftv (Tivdak) for the treatment of patients with recurrent or metastatic cervical …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. NCOA ONCOLOGY DRUG NEWSLETTER J U N E 2 0 2 4 FDA APPROVALS Tisotumab vedotin-tftv (Tivdak) The FDA has granted full approval to tisotumab vedotin-tftv (Tivdak) for the treatment of patients with recurrent or metastatic cervical …
June 20, 2024
Exploring the Evolving Treatment Landscape for PNH: Improving Patient Outcomes with Team-Based Care This live, virtual symposium will feature presentations detailing the diagnostic workup and treatment options for PNH. Learn More
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER J U N E 2 0 2 4 FDA APPROVALS Tisotumab vedotin-tftv (Tivdak) The FDA has granted full approval to tisotumab vedotin-tftv (Tivdak) for the treatment of patients with recurrent or metastatic cervical …
Explore the role of cardio-oncology in understanding and managing potential cardiovascular complications of immune checkpoint inhibitors.
June 20, 2024
How Can We Optimize the Real World Application of BCMA-Targeted Therapies for Our Patients with R/R Multiple Myeloma? This live, virtual symposium will bring together a nationally recognized expert in the management of multiple myeloma and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios. Learn More
The FDA OCE recognizes National Black Family Cancer Awareness Month in this compelling panel discussion that explores cancer care disparities and much more.
DLBCL/Aggressive NHL A Phase 1b Dose Escalation Study Of Metabolically Fit Cd19 Chimeric Antigen Receptor (Car) T Cells With Cd34 Selection Markers In Adult Patients With Relapsed Or Refractory Cd19 B Cell NHL and CLL/SLL - Patient population/Notes: This trial offers CD19 CAR T cell therapy manufactured here at MUSC/HCC to patients with relapsed B-cell NHL (DLBCL, FL, MCL, MZL, LPL, …
This is a visual representation of an online publication from the American Society of Clinical Oncology 2024 Annual Meeting, May 31 – June 4, 2024.
This is a visual representation of an online publication from the American Society of Clinical Oncology 2023 Annual Meeting, June 2 - 6, 2023.
June 18, 2024
Exploring the Evolving Treatment Landscape for PNH: Improving Patient Outcomes with Team-Based Care This live, virtual symposium will feature presentations detailing the diagnostic workup and treatment options for PNH. Learn More